Udayavni Special

Zydus Cadila gets permission from DCGI for phase-1 clinical trial of novel molecule ZYIL1


PTI, Dec 7, 2020, 12:29 PM IST

New Delhi: Drug firm Zydus Cadila on Monday said it has received permission from Drugs Controller General of India (DCGI) to initiate phase-1 clinical trial of its novel molecule ZYIL1, indicated for use as an inhibitor for inflammation condition ”NLRP3”.

In a regulatory filing, Zydus Cadila said “it has received permission to initiate the phase 1 clinical trial of ZYIL1, a novel oral small molecule NLRP3 inhibitor candidate. NLRP3 inflammasomes are involved in the inflammation process”.

This harmful inflammation within the body leads to the onset and development of various kinds of diseases, including Acute Respiratory Distress Syndrome (ARDS), auto-immune diseases, inflammatory diseases, cardiovascular diseases, metabolic disorders, Gastro-intestinal diseases (inflammatory bowel disease), renal diseases and CNS diseases, the company added.

Pankaj R Patel, Chairman, Cadila Healthcare said: “We will study the safety, tolerability, pharmacokinetics and pharmacodynamics of ZYIL1 in this phase I clinical trial in healthy human volunteers. We are committed to developing these pioneering novel treatments to the clinic for the patients in need.”

Last month, Zydus Cadila had filed the investigational new drug application for ZYIL1, positioned for management of critically ill COVID-19 patients.

Shares of Cadila Healthcare were trading 1.85 per cent higher at Rs 479.70 apiece on BSE.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

SC stays arrest of CM BSY in corruption case

K’taka COVID-19 update: 428 new cases, 760 discharges, 3 deaths on Jan 26

Bengaluru: Curfew within 2 kms of Vidhan Soudha during jt session

Two farmer unions withdraw from agitation against farm laws citing R-Day violence

FIR against farmer leader Rakesh Tikait over violence during tractor parade

IT min to launch ‘Work from Anywhere’ portal, Tejas virtual intelligence tool at NICSI event

Farmer who died at ITO protest had returned from Australia recently to celebrate his wedding


Related Articles More

K’taka COVID-19 update: 428 new cases, 760 discharges, 3 deaths on Jan 26

Unknown if vaccinated people can spread Covid-19: EMA

K’taka COVID-19 update: 529 new cases, 738 discharges, 4 deaths on Jan 25

AstraZeneca rejects ‘incorrect’ reports on Covid jab efficacy in elderly

K’taka becomes first state to vaccinate over 2 lakh in Phase 1

MUST WATCH

Farmers’ protest – confusion, conflict, analysis

Mangaluru: DK dist admin permits Kambala from Jan 30

Farmers across Country back Centre’s Farm Bills

KAMIL RAZA | Incredible Portrait Paintings by Artist from udupi

Deralakatte Ayyappa temple robbery case: Two arrested

Latest Additions

SC stays arrest of CM BSY in corruption case

25 students test positive for COVID-19 in Madikeri

K’taka COVID-19 update: 428 new cases, 760 discharges, 3 deaths on Jan 26

Bengaluru: Curfew within 2 kms of Vidhan Soudha during jt session

Cyber cops in 9 nations team up to disrupt dangerous malware

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.